Albemarle reported revenue of $5.14 billion for fiscal year 2025 (ended December 31, 2025), down 4.4% from fiscal year 2024. Net income was -$510.63 million, a net margin of 9.9% loss.
At the end of fiscal year 2025 it had total assets of $16.37 billion, total liabilities of $6.84 billion and shareholders' equity of $9.53 billion, with total debt of $3.19 billion.
Its operations brought in $1.28 billion of cash.
The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.
Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

Annual • USD
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | $5.1B | $5.4B | $9.6B | $7.3B | $3.3B |
| Gross profit | $673.5M | $63.9M | $1.2B | $3.1B | $998.0M |
| Operating income | -$366.6M | -$1.8B | $254.7M | $2.5B | $502.5M |
| Net income | -$510.6M | -$1.2B | $1.6B | $2.7B | $123.7M |
| Diluted EPS | – | – | – | – | $1.06 |
| Total assets | $16.4B | $16.6B | $18.3B | $15.5B | $11.0B |
| Total liabilities | $6.8B | $6.6B | $8.9B | $7.5B | $5.2B |
| Shareholders' equity | $9.5B | $10.0B | $9.4B | $8.0B | $5.6B |
| Cash | – | – | – | – | $439.3M |
| Total debt | $3.2B | $3.5B | $4.2B | $3.2B | $2.5B |
| Operating cash flow | $1.3B | $702.1M | $1.3B | $1.9B | $344.3M |
| Capital spending | – | – | – | – | $953.7M |
| Free cash flow | – | – | – | – | -$609.4M |
In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2020.
$5.14 billion, down 4.4% from $5.38 billion in fiscal year 2024.
Albemarle reported net income of -$510.63 million for fiscal year 2025 (9.9% of revenue); operating income was -$366.58 million.
At the end of fiscal year 2025: total debt of $3.19 billion.